Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$9,219,871
+$334,722 QoQ
Shares Held
36,303
-0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.56%
of 13F equity value
Holder Rank
#1,166
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legacy Private Trust Co. holds $43,660,786 across 7 Drug Manufacturers - General names. JNJ ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,088 | $21,695,290 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
36,303 | $9,219,871 | |
| 3 | ABBV |
AbbVie Inc.
|
33,151 | $8,342,116 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,709 | $2,147,106 | |
| 5 | AMGN |
Amgen Inc
|
4,257 | $1,541,544 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,655 | $441,081 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,167 | $273,778 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,219,871 | 36,303 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $8,885,149 | 36,349 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $8,224,192 | 39,740 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $7,779,109 | 41,954 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $6,349,511 | 41,568 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $6,719,505 | 40,518 | Shares | Sole | 2025-04-04 | |
| 2024-12-31 | $5,665,199 | 39,173 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $5,854,579 | 36,126 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $5,393,304 | 36,900 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $6,300,548 | 39,829 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $6,394,207 | 40,795 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $6,319,244 | 40,573 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $7,507,655 | 45,358 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $6,541,000 | 42,200 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $7,763,589 | 43,949 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $7,034,118 | 43,059 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $7,539,027 | 42,471 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $6,753,349 | 38,105 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $6,366,712 | 37,217 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $5,507,634 | 34,103 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $5,153,067 | 31,280 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $5,150,071 | 31,336 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $4,788,286 | 30,425 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $4,063,232 | 27,292 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $3,726,132 | 26,496 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $3,575,390 | 27,266 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||